I agree that this site is using cookies. You can find further informations here.
X
Gibney, Geoffrey T.
248  results:
Search for persons X
?
1

A paradigm shift in understanding vulvovaginal melanoma as ..:

Wilhite, Annelise M. ; Wu, Sharon ; Xiu, Joanne...
Gynecologic Oncology.  188 (2024)  - p. 13-21 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Individualised neoantigen therapy mRNA-4157 (V940) plus pem..:

Weber, Jeffrey S ; Carlino, Matteo S ; Khattak, Adnan...
The Lancet.  403 (2024)  10427 - p. 632-644 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Correction: Combination of Itacitinib or Parsaclisib with P..:

Munster, Pamela ; Iannotti, Nicholas ; Cho, Daniel C....
Cancer Research Communications.  4 (2024)  3 - p. 785-785 , 2024
Link: https://doi.org/10.1158/..
 
?
4

Combination of Itacitinib or Parsaclisib with Pembrolizumab..:

Munster, Pamela ; Iannotti, Nicholas ; Cho, Daniel C....
Cancer Research Communications.  3 (2023)  12 - p. 2572-2584 , 2023
Link: https://doi.org/10.1158/..
 
?
5

Society for Immunotherapy of Cancer (SITC) clinical practic..:

Pavlick, Anna C ; Ariyan, Charlotte E ; Buchbinder, Elizabeth I...
Journal for ImmunoTherapy of Cancer.  11 (2023)  10 - p. e006947 , 2023
Link: https://doi.org/10.1136/..
 
?
6

Multi-omic profiling reveals discrepant immunogenic propert..:

In, Gino K. ; Ribeiro, Jennifer R. ; Yin, Jun...
npj Precision Oncology.  7 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
7

Transcriptional Profiling of Malignant Melanoma Reveals Nov..:

Darabi, Sourat ; Elliott, Andrew ; Braxton, David R....
Cancers.  14 (2022)  6 - p. 1505 , 2022
Link: https://doi.org/10.3390/..
 
?
8

First-in-Human Phase I/II ICONIC Trial of the ICOS Agonist ..:

Yap, Timothy A. ; Gainor, Justin F. ; Callahan, Margaret K....
Clinical Cancer Research.  28 (2022)  17 - p. 3695-3708 , 2022
Link: https://doi.org/10.1158/..
 
?
9

Volume of Disease as a Predictor for Clinical Outcomes in P..:

Burke, Aidan M. ; Carrasquilla, Michael ; Jean, Walter C....
Frontiers in Oncology.  11 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
10

Standard-Dose Pembrolizumab Plus Alternate-Dose Ipilimumab ..:

Long, Georgina V. ; Robert, Caroline ; Butler, Marcus O....
Clinical Cancer Research.  27 (2021)  19 - p. 5280-5288 , 2021
Link: https://doi.org/10.1158/..
 
?
11

PET/CT scan and biopsy-driven approach for safe anti-PD-1 t..:

Gibney, Geoffrey T. ; Zaemes, Jacob ; Shand, Shelly...
Journal for ImmunoTherapy of Cancer.  9 (2021)  10 - p. e002955 , 2021
Link: https://doi.org/10.1136/..
 
?
12

A Multicenter Analysis of Immune Checkpoint Inhibitors as A..:

Randall Patrinely Jr.,, J. ; Funck-Brentano, Elisa ; Nguyen, Khang...
The Oncologist.  26 (2020)  3 - p. e505-e507 , 2020
Link: https://doi.org/10.1002/..
 
?
13

The current state of molecular testing in the treatment of ..:

El‐Deiry, Wafik S. ; Goldberg, Richard M. ; Lenz, Heinz‐Josef...
CA: A Cancer Journal for Clinicians.  69 (2019)  4 - p. 305-343 , 2019
Link: https://doi.org/10.3322/..
 
?
14

Choice of first‐line therapy in metastatic melanoma:

Gibney, Geoffrey T. ; Atkins, Michael B.
Cancer.  125 (2019)  5 - p. 666-669 , 2019
Link: https://doi.org/10.1002/..
 
?
15

Safety and efficacy of immune checkpoint inhibitors (ICIs) ..:

Shah, Neil J. ; Al-Shbool, Ghassan ; Blackburn, Matthew...
Journal for ImmunoTherapy of Cancer.  7 (2019)  1 - p. , 2019
Link: https://doi.org/10.1186/..
 
1-15